[ad_1] As Sandoz prepares to become standalone company, the generic and biosimilar firm has declared it will base itself in Basel, facilitating closer collaboration. Following its announced separation from Novartis…
Tag: Sandoz
Novartis unit Sandoz starts trading at 24 Swiss francs after completing spinoff
[ad_1] The Swiss drugmaker announced intentions to spin off the Sandoz business in August, offering stakeholders one Sandoz share for every five Novartis shares via a dividend-in-kind distribution. Novartis said…
Novartis’ Sandoz valued at $11.2 bln in market debut
[ad_1] A sign marks the Novartis Institutes for BioMedical Research facility in Cambridge, Massachusetts, U.S., June 16, 2021. REUTERS/Brian Snyder/File Photo Acquire Licensing Rights Oct 4 (Reuters) – Sandoz (SDZ.S)…
Sandoz dials up product launch plans ahead of market debut
[ad_1] By Ludwig Burger and Paul Arnold FRANKFURT, Sept 15 (Reuters) – Sandoz plans to launch at least five additional biologic drugs, its CEO Richard Saynor said, as the generics…
Samsung, Sandoz sign deal to commercialize biosimilar SB17
[ad_1] Samsung Bioepis headquarters in Songdo, Incheon [SAMSUNG BIOEPIS] Samsung Bioepis signed an agreement with Switzerland’s Sandoz for the sales of its Stelara biosimilar drug in the North American…
Novartis plans to spin off Sandoz in October
[ad_1] Receive free Novartis AG updates We’ll send you a myFT Daily Digest email rounding up the latest Novartis AG news every morning. Novartis is planning to list its generics…
Sandoz plans move to new central Basel headquarters by mid-2024, following proposed spin-off as standalone company
[ad_1] Sandoz AG to remain based in Basel, Switzerland following proposed spin-off from Novartis Announcement of planned city-center HQ marks important milestone as Sandoz prepares to become independent company Basel,…